Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.47
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Underperform
May 14, 2014 7:41 AM EDTBofA/Merrill Lynch downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Neutral to Underperform and cut their price target to $42.50 citing poor execution at the operational level.
Analyst Manoj Garg notes Dr Reddys (DRRD) 4Q PAT at Rs4.8bn (up 4% YoY) was -19% below the... More
Morgan Stanley Downgrades Dr. Reddy's Laboratories (RDY) to Equalweight
May 14, 2014 7:32 AM EDTMorgan Stanley downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.
Shares of Dr. Reddy's Laboratories closed at $43.82 yesterday.
... More